- Home
- GAMB vs ICUCW Comparison
GAMB vs ICUCW Comparison
Compare GAMB & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAMB
- ICUCW
- Stock Information
- Founded
- GAMB 2006
- ICUCW N/A
- Country
- GAMB Jersey
- ICUCW United States
- Employees
- GAMB N/A
- ICUCW 19
- Industry
- GAMB Services-Misc. Amusement & Recreation
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- GAMB Consumer Discretionary
- ICUCW Health Care
- Exchange
- GAMB Nasdaq
- ICUCW Nasdaq
- Market Cap
- GAMB N/A
- ICUCW N/A
- IPO Year
- GAMB 2021
- ICUCW 2021
- Fundamental
- Price
- GAMB $8.26
- ICUCW $0.04
- Analyst Decision
- GAMB Strong Buy
- ICUCW
- Analyst Count
- GAMB 8
- ICUCW 0
- Target Price
- GAMB $15.38
- ICUCW N/A
- AVG Volume (30 Days)
- GAMB 990.5K
- ICUCW N/A
- Earning Date
- GAMB 08-14-2025
- ICUCW N/A
- Dividend Yield
- GAMB N/A
- ICUCW N/A
- EPS Growth
- GAMB N/A
- ICUCW N/A
- EPS
- GAMB 0.40
- ICUCW N/A
- Revenue
- GAMB $147,655,000.00
- ICUCW N/A
- Revenue This Year
- GAMB $38.38
- ICUCW N/A
- Revenue Next Year
- GAMB $11.89
- ICUCW N/A
- P/E Ratio
- GAMB $20.84
- ICUCW N/A
- Revenue Growth
- GAMB 27.57
- ICUCW N/A
- 52 Week Low
- GAMB $8.04
- ICUCW N/A
- 52 Week High
- GAMB $17.14
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- GAMB 31.20
- ICUCW N/A
- Support Level
- GAMB $8.45
- ICUCW N/A
- Resistance Level
- GAMB $8.46
- ICUCW N/A
- Average True Range (ATR)
- GAMB 0.28
- ICUCW 0.00
- MACD
- GAMB 0.02
- ICUCW 0.00
- Stochastic Oscillator
- GAMB 24.86
- ICUCW 0.00
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.